Clinical Trial Update: Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on the Phase 1/Phase 2 safety and efficacy study of NUV-1511 in adults with advanced solid tumors, including HER2-negative breast cancer, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Castration-resistant Prostate Cancer
• Ovarian Cancer
• Pancreatic Cancer

Drugs mentioned

• NUV-1511

Snippet

Sponsor: Nuvation Bio Inc. | Conditions: Advanced Solid Tumor, HER2-negative Breast Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING